Futerman, Anthony H.
Weizmann Institute of Science
6 papers on CoChatORCID 0000-0003-0013-0115
Most cited papers
- Verified
Mammalian ceramide synthases
Levy, M., & Futerman, A. H. (2010) · IUBMB Life
Sphingolipid Metabolism and SignalingLysosomal Storage Disorders Research
Cited by 632
- Verified
When Do Lasses (Longevity Assurance Genes) Become CerS (Ceramide Synthases)?
Pewzner-Jung, Y., Ben-Dor, S., & Futerman, A. H. (2006) · Journal of Biological Chemistry
Sphingolipid Metabolism and SignalingLysosomal Storage Disorders Research
Cited by 435
- Verified
Signalome-wide RNAi screen identifies GBA1 as a positive mediator of autophagic cell death
Dasari, S. K., Bialik, S., Levin-Zaidman, S., Levin-Salomon, V., Merrill, A. H., Futerman, A. H., & Kimchi, A. (2017) · Cell Death & Differentiation
Autophagy in Disease and TherapyCell death mechanisms and regulation
Cited by 95
- Verified
Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans: Membrane lipid topography and fungal pathogenicity
Singh, A., Wang, H., Silva, L. C., Na, C., Prieto, M., Futerman, A. H., Luberto, C., & Del Poeta, M. (2012) · Cellular Microbiology
Fungal Infections and StudiesSphingolipid Metabolism and Signaling
Cited by 81
- Verified
Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutation
Blumenreich, S., Nehushtan, T., Barav, O. B., Saville, J. T., Dingjan, T., Hardy, J., Fuller, M., & Futerman, A. H. (2022) · npj Parkinson's Disease
Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments
Cited by 31
- Verified
Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid
Kim, J. L., Mestre, B., Shin, S.-H., & Futerman, A. H. (2021) · Cellular Signalling
Sphingolipid Metabolism and SignalingLysosomal Storage Disorders Research
Cited by 25
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free